Is Thrombolysis Only for a Crisis?

Size: px
Start display at page:

Download "Is Thrombolysis Only for a Crisis?"

Transcription

1 Is Thrombolysis Only for a Crisis? December 19, 2017 Is Thrombolysis Only for a Crisis? Indications for Thrombolytic Therapy in Patients with Acute Pulmonary Embolism Case Scenario A 28 year old woman with a history of systemic lupus erythematosus (SLE) and recurrent miscarriages presented to the emergency department (ED) with right sided chest pain and shortness of breath (SOB). On examination she had a pulse of 132, blood pressure of 98/60 and an oxygen saturation of 90% on 3L/min of supplemental oxygen (administered via a nasal cannula). The ED attending suspected pulmonary embolism (PE) and ordered a stat chest CT angiography. The chest CT revealed a large acute PE in the right pulmonary artery (PA) extending to the descending branch of the right PA. The patient was given a bolus of IV heparin then started on a heparin drip and admitted to the medical floor. Doppler ultrasound of the lower extremities was ordered to assess for deep vein thrombosis (DVT). A routine transthoracic echocardiogram (TTE) was also ordered to assess for right ventricular (RV) dysfunction and evaluate for pulmonary hypertension. Eight hours following admission, before the Doppler ultrasound or TTE were obtained, the patient experienced worsening SOB. The nurse assigned to the patient contacted the respiratory therapist on duty and the patient s physician. Based on the nurse s report of the patient s condition, the admitting physician consulted the pulmonologist Page 1 of 5

2 on call for his opinion regarding thrombolytic therapy. Twenty minutes later when the pulmonologist arrived, the patient s breathing was labored, her oxygen saturation was 88% on a non re-breather face mask, her pulse was 146, and her blood pressure was 83/48. The pulmonologist immediately requested an intubation kit and placed a stat order for tissue plasminogen activator (tpa). While the team was setting up the intubation tray and just as the pharmacist was entering the room with the tpa, the patient coded. Cardiopulmonary resuscitation was initiated and tpa was started. The patient failed to respond to resuscitation and died ten hours after admission. The patient s family sued, alleging that the admitting doctor failed to recognize the patient s clinical severity and failed to consult the pulmonary specialist and give tpa in a timely manner. Discussion Patients with PE vary from stable, with no need for supplemental oxygen, to critically unstable with significant oxygen requirements and imminent cardiac collapse. In some cases indications for thrombolytic use may be clear, with no contraindications, making the decision straight-forward. In many instances however, indications are weak or unclear and contraindications may be present, raising concerns. In the case presented above, both the ED physician and the admitting physician assessed the patient as appropriate for anticoagulation with heparin alone as the initial therapy. A closer look at this case revealed that in addition to having tachycardia, commonly seen with PE, the patient s BP was decreased on presentation and her clot burden was fairly large. Although the patient was not initially in shock, a more expeditious assessment of her RV function (via echocardiography) may have persuaded her doctors to consider administration of tpa at an earlier point in her clinical course. While her PE was diagnosed in a timely manner, the degree of her hemodynamic compromise was not fully appreciated. Anticoagulation, the standard of care for venous thromboembolic disease, prevents propagation of an existing clot and formation of new clots but does not cause lysis of an existing thrombus. In cases where a thrombus causes significant vascular occlusion associated with cardiovascular collapse, thrombolytic therapy may be warranted to restore hemodynamic stability. Studies indicate that thrombolytic therapy results in early hemodynamic improvement among patients with PE but, unfortunately, is associated with an increased risk of major bleeding. In addition, the impact of thrombolytic therapy on PE related mortality or recurrence of thromboembolism is unclear. Thus, the decision to use thrombolytic therapy in patients with acute PE needs to be individualized and the benefits must always be weighed against the risks. Thrombolytic therapy is typically reserved for cases of confirmed PE, given the associated risk for major bleeding, and is avoided when PE is merely suspected. Indications for Thrombolytic Therapy in patients with PE The most consistently agreed upon indication for use of thrombolytic therapy in patients with acute PE is the presence of hemodynamic instability. Typically hemodynamic instability is associated with hypotension from obstructive shock. Less often, individuals may be able to maintain a blood pressure at the lower limit of normal in the face of significant right ventricular compromise. Echocardiography can be used to assess for right ventricular dysfunction and to identify the presence of septal deviation in persons with pulmonary embolism. Another echocardiographic parameter that has prognostic value in the setting of PE is the ratio of the right ventricular (RV) end-diastolic diameter to the left ventricular (LV) end-diastolic diameter. The mortality associated with PE three months after the event increases in a step-wise manner once the RV/LV is? 1.0. Elevated troponin levels and/or significantly increased brain natriuretic peptide levels also portend a poor prognosis in individuals with PE. In addition to the presence of hemodynamic instability, other possible indications for thrombolytic therapy in patients with PE include: Right ventricular (RV) dysfunction (identified on echocardiography) Large clot burden Cardiopulmonary arrest due to PE Free floating (intra-cardiac) thrombus Page 2 of 5

3 Management of obstructive shock in the setting of PE often warrants removal of the obstructive thrombus to restore hemodynamic stability. In cases where the risk of bleeding is unduly high or a contraindication to thrombolytic therapy exists, mechanical removal of the thrombotic material may be attempted via surgery or an endovascular approach. If a decision is made to give thrombolytic therapy, the thrombolytic agent may be administered systemically or via a catheter-directed approach. Use of thrombolytic therapy for acute PE with RV dysfunction in the absence of shock remains controversial since few studies have examined the benefit of thrombolysis in this group. The largest randomized study looking at use of thrombolytic therapy in normotensive patients with acute PE and RV dysfunction, the Pulmonary Embolism Thrombolysis (PEITHO) trial, revealed that fibrinolysis prevented hemodynamic decompensation in patients with intermediate-risk PE but increased the risk of major hemorrhage and stroke. Hence, while thrombolytic therapy may seem appropriate for individuals with severe RV dysfunction, given the bleeding risks involved, the decision gets complicated when RV dysfunction is only mild to moderate in severity. To justify the use of thrombolytics the benefits should clearly outweigh any risks involved. Presence of other poor prognostic clinical indicators, such as high oxygen requirements, elevated troponin levels and/or highly elevated brain natriuretic peptide (BNP) levels, may lend support to a decision to use thrombolytic therapy in the setting of RV dysfunction without shock. Patients with PE who have a significant clot burden but are hemodynamically stable are sometimes given thrombolytic therapy due to concerns that they will experience pulmonary hypertension (PH) and RV dysfunction. Evidence to support this practice is lacking. A single study comparing use of heparin alone to use of heparin in combination with lower-dose tissue plasminogen activator (tpa) among patients with moderate PE showed lower rates of PH, faster resolution of PH and similar risk of bleeding in the group that received combination therapy. The trial, titled Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT), defined moderate PE as signs and symptoms of PE PLUS >70 percent embolism in?2 lobar arteries or main PA on CT pulmonary angiogram OR a high probability ventilation/perfusion (V/Q) scan showing V/Q mismatch in? 2 lobes. Despite the significant findings noted in the MOPPETT trial, the sample size was small (121) thus this one study cannot be used to guide clinical practice. Decisions regarding use of fibrinolytic therapy to treat PE in patients who experience cardiopulmonary arrest or who have a free floating intra-cardiac clot should be made on an individual basis as there is no clear evidence against or in support of this practice. Contraindications to Thrombolytic Therapy for PE The relative and absolute contraindications to thrombolytic therapy in patients with acute PE are listed below. Relative Contraindications: Severe uncontrolled hypertension on presentation (SBP >180 mmhg or DBP >110 mmhg) History of chronic, severe, poorly controlled hypertension History of ischemic stroke more than three months prior Traumatic or prolonged (>10 minute) CPR or major surgery less than three weeks prior Recent (within two to four weeks) internal bleeding Non-compressible vascular punctures Recent invasive procedure For streptokinase/anistreplase - Prior exposure (more than five days ago) or prior allergic reaction to these agents Pregnancy Active peptic ulcer Pericarditis or pericardial fluid Current use of anticoagulant (eg, warfarin sodium) that has produced an elevated international normalized ratio (INR) >1.7 or prothrombin time (PT) >15 seconds Age >75 years Diabetic retinopathy Page 3 of 5

4 Absolute Contraindications: Known intracranial neoplasm Intracranial or spinal surgery or trauma History of intracranial hemorrhage Known structural cerebral vascular lesion Ischemic stroke within three months (excluding stroke within three hours*) Suspected aortic dissection Active bleeding or bleeding diathesis (excluding menses) Significant closed-head trauma or facial trauma within three months * The American College of Cardiology (ACC) suggests that select stroke patients may benefit from thrombolytic therapy within 4.5 hours of symptom onset. Concluding Remarks/Key Points The benefit of thrombolytic therapy in the setting of acute PE complicated by shock has been widely accepted however, there are many cases of acute PE where the indication for thrombolytic therapy remains unclear, thus additional studies are needed to determine which other patient populations with PE would benefit from thrombolytics. The risks and benefits of thrombolytic therapy should be carefully weighed in each patient before a decision is made to administer a thrombolytic agent. When the indication for thrombolytic therapy is unclear, it is prudent to obtain the opinion of a specialist (with experience in treating PE and knowledge of the current PE guidelines) early in the patient s clinical course. Clinical scenarios where thrombolytics could be considered for treating PE: Cases where the individual has a high clot burden and evidence of RV dysfunction on echocardiography even if the individual does not demonstrate hemodynamic instability Cases where an individual has cardiac arrest secondary to PE Several references and resources are provided below. References and Resources Chatterjee S, Chakraborty A, Weinberg I, et. al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA Jun;311(23): Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation Aug;110(6): Meyer G, Vicaut E, Danays T. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med Apr 10;370(15): Sharifi M1, Bay C, Skrocki L, et. al. Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol Jan 15;111(2): Sista AK, Kearon C. Catheter-Directed Thrombolysis for Pulmonary Embolism: Where Do We Stand? JACC Cardiovasc Interv Aug 24;8(10): Kearon C, Akl EA, Comerota AJ, et. al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S. Page 4 of 5

5 Victor F. Tapson. Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis. UpToDate (Accessed December 19, 2016 The information provided in this resource does not constitute legal, medical or any other professional advice, nor does it establish a standard of care. This resource has been created as an aid to you in your practice. The ultimate decision on how to use the information provided rests solely with you, the PolicyOwner. Source URL: Page 5 of 5

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician

Management of Acute Pulmonary Embolism. Judith Hurdman Consultant Respiratory Physician Management of Acute Pulmonary Embolism Judith Hurdman Consultant Respiratory Physician Judith.hurdman@sth.nhs.uk Overview Risk Stratification Who can be managed as an outpatient? To thrombolyse or not

More information

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS. RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS. Target Audience: Physicians managing adult patients with massive and submassive pulmonary emboli in the

More information

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Catheter-based thrombolysis Local administration of lytic agent Higher local

More information

Epidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic

Epidemiology: Incidence VTE: Mortality  Morbidity Risk Factors: Acute Chronic : Genetic Submassive PE Pulmonary Embolism Epidemiology: Incidence VTE: 100-200/100,000 = 3rd most frequent cardiovascular disease Symptomatic DVT complicated by PE = 40-50% Sudden fatal PE = 34% Intermediate-risk

More information

Catheter-directed Thrombolysis for Pulmonary Embolism

Catheter-directed Thrombolysis for Pulmonary Embolism Catheter-directed Thrombolysis for Pulmonary Embolism Is It Good Advice to Lyse? Texas Society of Health-System Pharmacists April 7, 2018 Rebecca L. Attridge, PharmD, MSc, BCPS Associate Professor, University

More information

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis Prof. Ralf R.Kolvenbach MD,PhD,FEBVS Conflict of Interest BTG Standard PE therapy ANTICOAGULATION (AC) HEPARIN

More information

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT OBJECTIVE: To provide a diagnostic algorithm and treatment options for patients with acute pulmonary embolism (PE). BACKGROUND: Venous thromboembolism (VTE)

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACTIVASE (t-pa) FOR ACUTE MYOCARDIAL INFARCTION I. PURPOSE: A. To reduce the extent of myocardial infarction by lysing the clot in

More information

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group

Use of EKOS Catheter in the management of Venous Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Use of EKOS Catheter in the management of Venous Thromboembolism @ Mr. Manoj Niverthi, Mr. Sarang Pujari, and Ms. Nupur Dandavate, The GTF Group Introduction Georgia Thrombosis Forum (GTF, www.gtfonline.net)

More information

Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions

Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions Massive and Submassive Pulmonary Embolism: 2017 Update and Future Directions Kush R Desai, MD Assistant Professor of Radiology Northwestern University Feinberg School of Medicine Chicago, IL Disclosures

More information

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting Disclosure Thrombolysis in PE Daniel P. Hays, PharmD, BCPS, FASHP reports no relevant financial relationships. Daniel P. Hays, PharmD, BCPS, FASHP Outline 55 YOF presents to ED with SOB PMH of DVT + noncompliance

More information

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS.

RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS. DRAFT-2018 UPDATES RECOMMENDATIONS FOR THE MANAGEMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLISM IN ADULT PATIENTS. Target Audience: MultiCare physicians managing adult patients with massive and submassive

More information

Heart Health ESC Guidelines on the diagnosis and management of acute pulmonary embolism

Heart Health ESC Guidelines on the diagnosis and management of acute pulmonary embolism Heart Health Open Access Received: Oct 22, 2014 Accepted: Dec 01, 2014 Published: Dec 05, 2014 http://dx.doi.org/10.14437/hhoa-1-105 Review Jiri Widimsky, Heart Health Open Access 2014, 1:1 2014 ESC Guidelines

More information

Disclosures. Objectives

Disclosures. Objectives BRIGHAM AND WOMEN S HOSPITAL Treatment of Massive and Submassive Pulmonary Embolism Gregory Piazza, MD, MS Assistant Professor of Medicine Harvard Medical School Staff Physician, Cardiovascular Division

More information

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality

More information

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT

Acute Pulmonary Embolism and Deep Vein Thrombosis. Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center COPYRIGHT Acute Pulmonary Embolism and Deep Vein Thrombosis Barbara LeVarge MD Beth Israel Deaconess Medical Center Pulmonary Hypertension Center Acute PE and DVT No disclosures. Acute PE and DVT Learning objectives

More information

National Institute for Health and Care Excellence

National Institute for Health and Care Excellence National Institute for Health and Care Excellence IP1243 Ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism Consultation Comments table IPAC date: Thursday 12 March 2015 1 1 Manufacturer

More information

Epidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment

Epidemiology. Update on Pulmonary Embolism. Keys to PE Management 5/5/2014. Diagnosis. Risk stratification. Treatment Update on Pulmonary Embolism Steven M. Dean, DO, FACP, RPVI Program Director- Vascular Medicine Associate Professor of Internal Medicine Division of Cardiovascular Medicine The Ohio State University Keys

More information

Bilateral Central Pulmonary Embolism and Recent History of Ischemic Stroke

Bilateral Central Pulmonary Embolism and Recent History of Ischemic Stroke WHAT WOULD YOU DO? Bilateral Central and Recent History of Ischemic Stroke MODERATOR: KEITH M. STERLING, MD PANEL: JAMES F. BENENATI, MD; NOAH J. JONES, MD, FACC, FSCAI; AND AKHILESH K. SISTA, MD, FSIR

More information

Case. Case. Management of Pulmonary Embolism in the ICU

Case. Case. Management of Pulmonary Embolism in the ICU Management of Pulmonary Embolism in the ICU Todd M Bull, M.D. Associate Professor of Medicine Division of Pulmonary Sciences and Critical Care Medicine Pulmonary Hypertension Center University of Colorado

More information

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is

More information

ST Elevated Myocardial Infarction- Latest AHA recommendations

ST Elevated Myocardial Infarction- Latest AHA recommendations ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to

More information

CARDIAC PROBLEMS IN PREGNANCY

CARDIAC PROBLEMS IN PREGNANCY CARDIAC PROBLEMS IN PREGNANCY LAS VEGAS, NEVADA, USA 27 February 1 March 2016 SUCCESSFUL TREATMENT WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR OF MASSIVE PULMONARY EMBOLISM IN THE 16 TH WEEK OF PREGNANCY

More information

Single-Center, Retrospective, Observational Analysis of Patients with Submassive Pulmonary Embolism (PE) Receiving Catheter- Directed Thrombolysis

Single-Center, Retrospective, Observational Analysis of Patients with Submassive Pulmonary Embolism (PE) Receiving Catheter- Directed Thrombolysis Single-Center, Retrospective, Observational Analysis of Patients with Submassive Pulmonary Embolism (PE) Receiving Catheter- Directed Thrombolysis John A. Phillips, M.D. OhioHealth Heart and Vascular Physicians

More information

Epidemiology of Pulmonary Embolism (PE)

Epidemiology of Pulmonary Embolism (PE) Why Treat Submassive PE Abstract: Massive Pulmonary Embolism (PE) requires immediate lifesaving intervention for the patient. For the submassive PE patient, characterized by presence of right ventricular

More information

What is New in Acute Pulmonary Embolism? Interventional Treatment. Prof. Nils Kucher University Hospital Bern Switzerland

What is New in Acute Pulmonary Embolism? Interventional Treatment. Prof. Nils Kucher University Hospital Bern Switzerland What is New in Acute Pulmonary Embolism? Interventional Treatment Prof. Nils Kucher University Hospital Bern Switzerland nils.kucher@insel.ch Disclosure of Interest Dr. Kucher received research grants

More information

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases

More information

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not

More information

Acute Management of Pulmonary Embolism

Acute Management of Pulmonary Embolism Acute Management of Pulmonary Embolism Dr Alex West Respiratory Consultant Guy s and St Thomas Hospital London Declarations - none Order of Play Up date in Diagnostic Imaging - CTPA and V:Q SPECT Sub-massive

More information

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year. Venous Thrombosis Magnitude of the Problem DVT 2 Million Postthrombotic Syndrome 800,000 PE 600,000 Death 60,000 Silent PE 1 Million Pulmonary Hypertension 30,000 Estimated Cost of VTE Care $1.5 Billion/year

More information

Management of Massive and Sub-Massive Pulmonary Embolism

Management of Massive and Sub-Massive Pulmonary Embolism Management of Massive and Sub-Massive Pulmonary Embolism M. Montero-Baker, MD L Leon Jr., MD, RVT, FACS Tucson Medical Center Vascular and Endovascular Surgery Section CASE PRESENTATION 54 YEAR- OLD CAUCASIAN

More information

National Institute for Health and Care Excellence

National Institute for Health and Care Excellence National Institute for Health and Care Excellence IP1219 Ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis Consultation table IPAC date: Thursday 12 March 2015 Com. 1 3 NHS Professional

More information

RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain

RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain Potential Conflicts of Interest Financial conflicts of

More information

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School

Management of Pulmonary Embolism. Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School Management of Pulmonary Embolism Michael Hooper, M.D., MSc Associate Professor, Pulmonary and Critical Care Medicine Eastern Virginia Medical School I have no conflicts of interest to report. VTE Overview

More information

Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center

Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center The opinions expressed herein are solely those of the author and do not represent the official views of the Department of Defense

More information

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case September 19 th, 2013 Scott M Lilly, MD PhD Thrombolytics in 2013: Never Say Never Clinical Case 2 1 Evolution of STEMI Therapy The importance of absolute rest in bed for several days is clear James B

More information

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE Mark Goodwin, MD Disclosure Speaker name:... I have the following potential conflicts of interest to report:

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Guideline for Thrombolysis Therapy in Pulmonary Embolism

Guideline for Thrombolysis Therapy in Pulmonary Embolism Guideline for Thrombolysis Therapy in Pulmonary Embolism Dr Jane Strong Consultant Haematologist Trust ref: B24/2016 1. Introduction / Scope All Patients with pulmonary embolism (PE) require rapid risk

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS I. Purpose : A. To reduce morbidity and mortality associated

More information

The spectrum of clinical outcome of PE

The spectrum of clinical outcome of PE Practical treatment approach for patients with PE Cecilia Becattini University of Perugia The spectrum of clinical presentation of PE PE-related shock Mild clinical symptoms The spectrum of clinical outcome

More information

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS: 1. Is this a CMS inpatient only procedure? Yes, admit as inpatient, proceed to # 3 No, proceed to # 2 2. Do you expect that the patient s condition will require a hospital stay that will cross two midnights

More information

Med Sci Monit, 2016; 22: Grade D. Quality Outstanding

Med Sci Monit, 2016; 22: Grade D. Quality Outstanding Ain and Jaff. Treatment of Submassive Pulmonary Embolism: Knowing When to be Aggressive and When to be Conservative. Curr Treat Options Cardio Med (2015) 17:25. Review Article Akin et al. Catheter-Directed

More information

Management of sub-massive and massive pulmonary embolism:

Management of sub-massive and massive pulmonary embolism: Management of sub-massive and massive pulmonary embolism: Evidence and Controversy Boonsong Patjanasoontorn, MD, FCCP, FCCM Immediate Past President, Thai Society of Critical Care Medicine(TSCCM) Chief,

More information

2018 Early Management of Acute Ischemic Stroke Guidelines Update

2018 Early Management of Acute Ischemic Stroke Guidelines Update 2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital

More information

A 50-year-old woman with syncope

A 50-year-old woman with syncope Hira Shahzad 1, Ali Bin Sarwar Zubairi 2 1 Medical College, Aga Khan University Hospital, Karachi 2 Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan Ali Bin Sarwar Zubairi Associate

More information

Echocardiography as a diagnostic and management tool in medical emergencies

Echocardiography as a diagnostic and management tool in medical emergencies Echocardiography as a diagnostic and management tool in medical emergencies Frank van der Heusen MD Department of Anesthesia and perioperative Care UCSF Medical Center Objective of this presentation Indications

More information

October 2017 Pulmonary Embolism

October 2017 Pulmonary Embolism October 2017 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University 1 Objectives Epidemiology Pathophysiology Diagnosis Massive PE Treatment

More information

Chapter 1. Introduction

Chapter 1. Introduction Chapter 1 Introduction Introduction 9 Even though the first reports on venous thromboembolism date back to the 13 th century and the mechanism of acute pulmonary embolism (PE) was unraveled almost 150

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue

More information

Management of Intermediate-Risk Pulmonary Embolism

Management of Intermediate-Risk Pulmonary Embolism Management of Intermediate-Risk Pulmonary Embolism Stavros V. Konstantinides, MD, PhD, FESC Professor, Clinical Trials in Antithrombotic Therapy Center for Thrombosis und Hemostasis, University of Mainz,

More information

8/16/2012. Pulmonary Embolism

8/16/2012. Pulmonary Embolism Pulmonary Embolism Rita M. Williams, NP-C, PA PeaceHealth Medical Group, Pulmonary & Critical Care Pulmonary Embolism Acute pulmonary embolism (PE) is a common and frequently fatal disease Clinical presentation

More information

PE Pathway. The charts are listed as follows:

PE Pathway. The charts are listed as follows: PE Pathway This document comprises 6 simple flow charts to assist clinicians in the investigation and treatment of suspected or confirmed Acute Pulmonary Emboli. The pathway has been put together using

More information

EKOS. Interventional Vascular 3 February, Imagine where we can go.

EKOS. Interventional Vascular 3 February, Imagine where we can go. EKOS Interventional Vascular 3 February, 2015 Imagine where we can go. Forward-looking statement This presentation and information communicated verbally to you may contain certain projections and other

More information

Mark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine

Mark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine Pulmonary Embolism Response Teams Not So Fast Early Interventions is a House of Cards Mark H. Meissner, MD Peter Gloviczki Professor of Venous & Lymphatic Disorders University of Washington School of Medicine

More information

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital

Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital Is it safe to manage pulmonary embolism in Primary Care? Roopen Arya King s College Hospital A few definitions Safe Avoid death, recurrent thrombosis, bleeding Manage Diagnosis + treatment Pulmonary embolism

More information

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR

Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism. Rajat Deo, MD, MTR Understanding Best Practices in Anticoagulation Therapy in Patients with Venous Thromboembolism Rajat Deo, MD, MTR Director of Translational Research in Cardiac Arrhythmias Division of Cardiovascular Medicine

More information

Severe pulmonary embolism: surgical aspects. Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland

Severe pulmonary embolism: surgical aspects. Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland Severe pulmonary embolism: surgical aspects Oliver Reuthebuch Clinic for Cardiac Surgery University Hospital Basel Switzerland Severe pulmonary embolism Acute pulmonary embolism Chronic pulmonary thromboembolism

More information

VTE & Medical Patients: Case Scenario

VTE & Medical Patients: Case Scenario The Saudi Association for Venous Thromboembolism SAVTE The 2 nd SAVTE Symposium 1-3 May, 2012 Casablanca, Morocco VTE & Medical Patients: Case Scenario Majdy Idrees Riyadh, Saudi Arabia Majdy M Idrees,

More information

Thrombolysis administration

Thrombolysis administration Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide

More information

Pulmonary embolism. Paweł Balsam

Pulmonary embolism. Paweł Balsam Pulmonary embolism Paweł Balsam Venous thromboembolism (VTE) Pulmonary embolism (PE) and deep vein thrombosis (DVT) are two clinical presentations of veonus thromboembolism Pulmonary embolism A pulmonary

More information

Interventional treatment for patients with acute pulmonary embolism

Interventional treatment for patients with acute pulmonary embolism Interventional treatment for patients with acute pulmonary embolism I. Petrov, I. Martinov Cardiology department Tokuda Hospital Sofia I. Petrov, Treatment and prophylaxis of PE Treatment of PE: 1.) Systemic

More information

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE 2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG Title: Author: Speciality/ Division: Directorate: Date Uploaded: Review Date: September 2019 CG ID TAG CG0423 CLINICAL GUIDELINES ID TAG Clinical Guideline for Alteplase in intra-arterial thrombolysis

More information

Pathophysiology of stroke

Pathophysiology of stroke A practical approach to acute stro ke Dr. Sanjith Aaron, M.D., D.M., Professor, Department of Neurosciences, CMC Vellore Stroke is characterized by an abrupt onset of neurological deficit lasting more

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

Interventional Management of Acute Pulmonary Embolism

Interventional Management of Acute Pulmonary Embolism Interventional Management of Acute Pulmonary Embolism Prof. Nils Kucher Angiology & Cardiology University Hospital Bern Inselspital nils.kucher@insel.ch DECLARATION OF CONFLICT OF INTEREST Consultant to

More information

Acute and long-term treatment of VTE. Cecilia Becattini University of Perugia

Acute and long-term treatment of VTE. Cecilia Becattini University of Perugia Acute and long-term treatment of VTE Cecilia Becattini University of Perugia Acute and long-term treatment of VTE The goals The acute PE phase After the acute phase Treatment for VTE Goals of acute treatment

More information

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Protocol for IV rtpa Treatment of Acute Ischemic Stroke Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and

More information

REVIEW ON PULMONARY EMBOLISM

REVIEW ON PULMONARY EMBOLISM REVIEW ON PULMONARY EMBOLISM * Shashi Kumar Yadav, Prof. Xiao Wei, Roshan Kumar Yadav, Sanjay Kumar Verma and Deepika Dhakal * Department of Medicine, Clinical College of Yangtze University, The first

More information

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT

More information

Cardiovascular Images

Cardiovascular Images Cardiovascular Images Pulmonary Embolism Diagnosed From Right Heart Changes Seen After Exercise Stress Echocardiography Brian C. Case, MD; Micheas Zemedkun, MD; Amarin Sangkharat, MD; Allen J. Taylor,

More information

Surgical Thrombectomy for PE: Is it Making a Comeback

Surgical Thrombectomy for PE: Is it Making a Comeback Surgical Thrombectomy for PE: Is it Making a Comeback Prashanth Vallabhajosyula, MD MS The University of Pennsylvania Health System Philadelphia, PA Case - 84 year old female presents with submassive right

More information

Critical Review Form Therapy

Critical Review Form Therapy Critical Review Form Therapy Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Lancet 1993; 341:501-511 Objective: To determine

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy

Pulmonary embolism: Acute management. Cecilia Becattini University of Perugia, Italy Pulmonary embolism: Acute management Cecilia Becattini University of Perugia, Italy Acute pulmonary embolism: Acute management Diagnosis Risk stratification Treatment Non-high risk PE: diagnosis 3-mo VTE

More information

Shock, Monitoring Invasive Vs. Non Invasive

Shock, Monitoring Invasive Vs. Non Invasive Shock, Monitoring Invasive Vs. Non Invasive Paula Ferrada MD Assistant Professor Trauma, Critical Care and Emergency Surgery Virginia Commonwealth University Shock Fluid Pressors Ionotrope Intervention

More information

PE is a difficult diagnosis that may be missed because of non-specific clinical presentation.

PE is a difficult diagnosis that may be missed because of non-specific clinical presentation. Pulmonary embolism (PE) is a relatively common cardiovascular emergency. By occluding the pulmonary arterial bed it may lead to acute life-threatening (3% early mortality rate), but potentially reversible

More information

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC

Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC Updates in Management of Pulmonary Embolism (PE) David Ming, MD Duke Hospital Medicine July 24, 2017 Hilton Head, SC Objectives Highlight clinical features and presentation of acute PE Analyze strategies

More information

Successful tenecteplase use in sudden shock from CT-proven massive pulmonary embolism

Successful tenecteplase use in sudden shock from CT-proven massive pulmonary embolism www.edoriumjournals.com CASE REPORT OPEN ACCESS PEER REVIEWED Successful tenecteplase use in sudden shock from CT-proven massive pulmonary embolism Jason P. Stopyra, William P. Bozeman ABSTRACT Introduction:

More information

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced

More information

When the learner has completed this module, she/he will be able to:

When the learner has completed this module, she/he will be able to: Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017

More information

PULMONARY EMBOLISM -CASE REPORT-

PULMONARY EMBOLISM -CASE REPORT- University Goce Delcev, Faculty of Medical sciences, Stip University Clinic of Cardiology, Skopje R. Of Macedonia PULMONARY EMBOLISM -CASE REPORT- Gordana Kamceva MD mr.sci Acknowledgment Marija Vavlukis

More information

Acoustic Pulse Thrombolysis Treatment

Acoustic Pulse Thrombolysis Treatment Acoustic Pulse Thrombolysis Treatment BTGVascular.com SETTING THE STANDARD FOR VASCULAR THERAPIES Quickly & safely dissolve thrombus with the EKOS System. The Acoustic Pulse Difference Acoustic Pulse Thrombolysis

More information

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke

More information

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia

Acute and long-term treatment of PE. Cecilia Becattini University of Perugia Acute and long-term treatment of PE Cecilia Becattini University of Perugia Acute and long-term treatment of VTE What is the optimal acute phase treatment for the patient? Intravenous thrombolysis One

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date: Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Systemic Fibrinolytic Therapy in the Presence of Absolute Contraindication; a Case Series

Systemic Fibrinolytic Therapy in the Presence of Absolute Contraindication; a Case Series Emergency. 2018; 6 (1): e25 CASE REPORT Systemic Fibrinolytic Therapy in the Presence of Absolute Contraindication; a Case Series Mahdi Pishgahi 1, Toktam Alirezaei 1, Behzad Hajimoradi 1, S. Mojtaba Nekooghadam

More information

Title: Repeated Thrombolytic Treatment for Recurrent Pulmonary Thromboembolism: A Report of 2 Cases and a Literature Review

Title: Repeated Thrombolytic Treatment for Recurrent Pulmonary Thromboembolism: A Report of 2 Cases and a Literature Review DOI: Manuscript type: Case Report Title: Repeated Thrombolytic Treatment for Recurrent Pulmonary Thromboembolism: A Report of 2 Cases and a Literature Review Running head: Repeated Thrombolytic Treatment

More information

VTE in Children: Practical Issues

VTE in Children: Practical Issues VTE in Children: Practical Issues Wasil Jastaniah MBBS,FAAP,FRCPC Consultant Pediatric Hem/Onc/BMT May 2012 Top 10 Reasons Why Pediatric VTE is Different 1. Social, ethical, and legal implications. 2.

More information

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer: When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation

More information

Risk-Based Evaluation and Management of VTE

Risk-Based Evaluation and Management of VTE 12:50-1:50pm Risk-Based Evaluation and Management of VTE SPEAKER Gregory Piazza, MD, MS BRIGHAM AND WOMEN S HOSPITAL Risk-Based Evaluation and Management of VTE Gregory Piazza, MD, MS Assistant Professor

More information

The Evidence Base for Treating Acute DVT

The Evidence Base for Treating Acute DVT The Evidence Base for Treating Acute DVT Mr Chung Sim Lim Consultant Vascular Surgeon and Honorary Lecturer Royal Free London NHS Foundation Trust and University College London NIHR UCLH Biomedical Research

More information

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism

Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism

More information

Local and systemic thrombolytic therapy for acute venous thromboembolism

Local and systemic thrombolytic therapy for acute venous thromboembolism Clin Chest Med 24 (2003) 73 91 Local and systemic thrombolytic therapy for acute venous thromboembolism Selim M. Arcasoy, MD, FCCP, FACP a,b, *, Anil Vachani, MD c a Pulmonary, Allergy, and Critical Care

More information

4/18/2018. Objectives. Background. 1) Compare and contrast the various validated tools for the identification of patients with pulmonary embolism

4/18/2018. Objectives. Background. 1) Compare and contrast the various validated tools for the identification of patients with pulmonary embolism Pulmonary Embolism: Assessment, risk-stratification, and treatment plan for the outpatient management of low-risk patients Presentation by Joshua T. Wood, PharmD/PGY-1 Resident Providence St. Patrick Hospital;

More information

Pulmonary Embolectomy:

Pulmonary Embolectomy: Pulmonary Embolectomy: Recommendation for early surgical intervention Tomas A. Salerno, M.D. Professor of Surgery, University of Miami Miller School of Medicine and Jackson Memorial Hospital Epidemiology

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information